SANGAMO THERAPEUTICS, INC (SGMO) Operating Income (Loss) USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Sangamo Therapeutics, Inc quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2024.
  • Sangamo Therapeutics, Inc Operating Income (Loss) for the quarter ending March 31, 2024 was -$51.5 M, a 386% decline year-over-year.
  • Sangamo Therapeutics, Inc Operating Income (Loss) for the twelve months ending March 31, 2024 was -$344 M, a 149% decline year-over-year.
  • Sangamo Therapeutics, Inc annual Operating Income (Loss) for 2023 was -$274 M, a 36.1% decline from 2022.
  • Sangamo Therapeutics, Inc annual Operating Income (Loss) for 2022 was -$201 M, a 9.79% decline from 2021.
  • Sangamo Therapeutics, Inc annual Operating Income (Loss) for 2021 was -$183 M, a 41.5% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$344 M -$51.5 M -$69.6 M -386% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$274 M -$62.1 M -$6.67 M -12% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-13
Q3 2023 -$267 M -$106 M -$51.5 M -93.8% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-01
Q2 2023 -$216 M -$124 M -$77.8 M -170% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 -$138 M $18 M +$63.3 M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$201 M -$55.4 M -$15.5 M -38.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-13
Q3 2022 -$186 M -$54.9 M -$6.46 M -13.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 -$179 M -$45.7 M +$2.97 M +6.09% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$182 M -$45.3 M +$1.04 M +2.25% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 -$183 M -$39.9 M +$3.53 M +8.14% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-13
Q3 2021 -$187 M -$48.4 M -$44.7 M -1209% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$142 M -$48.7 M -$10.8 M -28.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$131 M -$46.3 M -$1.78 M -4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$130 M -$43.4 M -$44.9 M -3057% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-23
Q3 2020 -$84.7 M -$3.7 M +$25.5 M +87.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$110 M -$37.9 M -$4.39 M -13.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$106 M -$44.5 M -$625 K -1.42% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 -$105 M $1.47 M +$22.2 M Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 -$127 M -$29.2 M -$13 M -80.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 -$114 M -$33.5 M -$14.4 M -75% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 -$100 M -$43.9 M -$22.9 M -109% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$77.2 M -$20.8 M -$7.01 M -50.9% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-24
Q3 2018 -$70.1 M -$16.2 M -$3.21 M -24.6% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 -$66.9 M -$19.1 M -$6.37 M -49.9% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 -$60.6 M -$21 M -$4.21 M -25% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 -$56.4 M -$13.8 M -$3.94 M -40% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-28
Q3 2017 -$52.4 M -$13 M +$6.17 M +32.1% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 -$58.6 M -$12.8 M +$14.1 M +52.4% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 -$72.7 M -$16.8 M -$111 K -0.67% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$72.6 M -$9.83 M +$5.84 M +37.3% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-01
Q3 2016 -$78.4 M -$19.2 M -$6.52 M -51.4% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$71.9 M -$26.8 M -$14.6 M -119% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 -$57.3 M -$16.7 M -$10.5 M -168% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 -$46.9 M -$15.7 M -$11.2 M -251% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-01
Q3 2015 -$35.7 M -$12.7 M -$5.03 M -65.7% Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-27
Q2 2015 -$30.6 M -$12.3 M -$5.23 M -74.2% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 -$25.4 M -$6.22 M +$1.39 M +18.3% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
Q4 2014 -$26.8 M -$4.47 M +$3.71 M +45.3% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-28
Q3 2014 -$30.5 M -$7.65 M -$1.5 M -24.3% Jul 1, 2014 Sep 30, 2014 10-Q 2015-10-30
Q2 2014 -$29 M -$7.05 M -$1.58 M -28.9% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
Q1 2014 -$27.4 M -$7.61 M -$706 K -10.2% Jan 1, 2014 Mar 31, 2014 10-Q 2015-04-28
Q4 2013 -$26.7 M -$8.17 M -$4.81 M -143% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-18
Q3 2013 -$21.9 M -$6.16 M -$357 K -6.15% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-28
Q2 2013 -$21.5 M -$5.47 M +$276 K +4.81% Apr 1, 2013 Jun 30, 2013 10-Q 2014-07-29
Q1 2013 -$21.8 M -$6.91 M +$378 K +5.19% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-07
Q4 2012 -$22.2 M -$3.37 M +$3 M +47.1% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-25
Q3 2012 -$25.2 M -$5.8 M +$3.77 M +39.4% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-04
Q2 2012 -$29 M -$5.74 M +$4.54 M +44.1% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-02
Q1 2012 -$33.5 M -$7.28 M +$2.32 M +24.1% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q4 2011 -$35.8 M -$6.37 M Oct 1, 2011 Dec 31, 2011 10-K 2014-02-24
Q3 2011 -$9.57 M -$859 K -9.86% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-02
Q2 2011 -$10.3 M -$6.4 M -165% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-03
Q1 2011 -$9.6 M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-07
Q3 2010 -$8.72 M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-04
Q2 2010 -$3.88 M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.